Report Feature
The future of the in-vitro toxicology testing market looks promising with opportunities in various applications, such as pharmaceuticals & biopharmaceuticals, cosmetic & household products, food, and chemicals. The global in-vitro toxicology testing market is expected to grow with a CAGR of 10%-12% from 2020 to 2025. The major drivers for this market are opposition to animal testing and increasing research & development expenditure to detect toxicity at an early stage during drug development.
A total of XX figures / charts and XX tables are provided in more than 150 pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global in-vitro toxicology testing market report, please download the report brochure.
In this market, consumables is the largest product & service segment of in-vitro toxicology testing, whereas pharmaceuticals & biopharmaceuticals is the largest end use industry. Growth in various segments of the consumables is the largest product & service segment of in-vitro toxicology testing, whereas pharmaceuticals & biopharmaceuticals is the largest end use industry market are given below:
The study includes trends and forecast for the global in-vitro toxicology testing market by product & service, method, toxicity endpoint & test, industry, technology, and region as follows:
By Product & Service [Value ($ Million) shipment analysis for 2014 – 2025]:
- Consumables
-
Assays
- Bacterial Toxicity Assays
- Enzyme Toxicity Assays
- Cell-based Elisa & Western Blots
- Receptor-binding Assays
- Tissue Culture Assays
- Other Assays
- Equipment
- Software
- Services
By Method [Value ($ Million) shipment analysis for 2014 – 2025]:
- Cellular Assays
- Biochemical Assays
- In Silico Models
- Ex Vivo Models
By Toxicity Endpoint & Test [Value ($ Million) shipment analysis for 2014 – 2025]:
- ADME
- Skin Irritation, Corrosion, & Sensitization
- Genotoxicity Testing
- Cytotoxicity Testing
- Ocular Toxicity
- Organ Toxicity
- Phototoxicity Testing
- Dermal Toxicity
- Other Toxicity Endpoints & Tests
By End Use Industry [Value ($ Million) shipment analysis for 2014 – 2025]:
- Pharmaceuticals & Biopharmaceuticals
- Cosmetic & Household Products
- Food
- Chemicals
By Technology [Value ($ Million) shipment analysis for 2014 – 2025]:
- Cell Culture Technologies
- High-throughput Technologies
- Toxicogenomics
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
-
North America
- United States
- Canada
- Mexico
-
Europe
- United Kingdom
- Spain
- Germany
- France
-
Asia Pacific
- China
- India
- Japan
-
The Rest of the World
- Brazil
Some of the in-vitro toxicology testing companies profiled in this report include Thermo Fisher Scientific, Covance, Bio-Rad Laboratories, GE Healthcare, Eurofins Scientific, Merck, Charles River Laboratories, Catalent, Cyprotex, SGS, QIAGEN, Promega Corporation, Gentronix, BioIVT, and MB Research Laboratories.
Lucintel forecasts that consumables will remain the largest product and service segment over the forecast period due to increasing demand for high-quality reagents and the repeated use of media and reagents in in-vitro toxicology studies.
Within this market, pharmaceuticals & biopharmaceuticals will remain the largest end use industry segment over the forecast period due to high usage of toxicology testing in pharmacokinetic analysis of novel and generic modified pharmaceutical products and presence of several drug candidates in the pipeline.
Asia Pacific will remain the largest region over the forecast period due to the emergence of CROs for outsourcing toxicology-related research projects, opposition to animal testing resulting in the use of alternate methods, increasing pharmaceutical drug pipeline, and growing consumer awareness of product safety in the region.
|
Features of the Global In-vitro Toxicology Testing Market |
|
|
This report answers following key questions |
|
Q.1 What are some of the most promising potential, high-growth opportunities for the global in-vitro toxicology testing market by by product & service (consumables, assays (bacterial toxicity assays, enzyme toxicity assays, cell-based elisa & western blots, receptor-binding assays, tissue culture assays, and other assays), equipment, software, and services), method (cellular assays, biochemical assays, in silico models, and ex vivo models), toxicity endpoint & test (ADME, skin irritation, corrosion, & sensitization, genotoxicity testing, cytotoxicity testing, ocular toxicity, organ toxicity, phototoxicity testing, dermal toxicity, and other toxicity endpoints & tests), end use industry (pharmaceuticals & biopharmaceuticals, cosmetic & household products, food, and chemicals), technology (cell culture technologies, high-throughput technologies, and toxicogenomics), and region (North America, Europe, Asia Pacific, and Rest of the World)? Q.2 Which segments will grow at a faster pace and why? Q.3 Which region will grow at a faster pace and why? Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global in-vitro toxicology testing market? Q.5 What are the business risks and threats to the global in-vitro toxicology testing market? Q.6 What are the emerging trends in this in-vitro toxicology testing market and the reasons behind them? Q.7 What are some changing demands of customers in this in-vitro toxicology testing market? Q.8 What are the new developments in this in-vitro toxicology testing market? Which companies are leading these developments? Q.9 Who are the major players in this in-vitro toxicology testing market? What strategic initiatives are being implemented by key players for business growth? Q.10 What are some of the competitive products and processes in this in-vitro toxicology testing market, and how big of a threat do they pose for loss of market share via material or product substitution? Q.11 What M&A activities did take place in the last five years in the global in-vitro toxicology testing market? |
Report Scope
| Key Features | Description |
| Base Year for Estimation | 2019 |
|
Trend Period (Actual Estimates) |
2014-2019 |
| Forecast Period | 2020-2025 |
| Pages | More than 150 |
| Market Representation / Units | Revenue in US $ Million |
| Report Coverage | Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling |
| Market Segments | Product & Service (Consumables, Assays (Bacterial Toxicity Assays, Enzyme Toxicity Assays, Cell-Based Elisa & Western Blots, Receptor-Binding Assays, Tissue Culture Assays, and Other Assays), Equipment, Software, and Services, Method (Cellular Assays, Biochemical Assays, In Silico Models, and Ex Vivo Models), Toxicity Endpoint & Test (ADME, Skin Irritation, Corrosion, & Sensitization, Genotoxicity Testing, Cytotoxicity Testing, Ocular Toxicity, Organ Toxicity, Phototoxicity Testing, Dermal Toxicity, and Other Toxicity Endpoints & Tests), End Use Industry (Pharmaceuticals & Biopharmaceuticals, Cosmetic & Household Products, Food, and Chemicals), and Technology (Cell Culture Technologies, High-Throughput Technologies, and Toxicogenomics) |
Regional Scope |
North America (USA, Mexico, and Canada), Europe (United Kingdom, Spain, Germany, and France), Asia (China, India, and Japan), and ROW ( Brazil) |
| Customization | 10% Customization without Any Additional Cost |
Table of Contents
1. Executive Summary
7.2 Emerging Trends in the Global In-Vitro Toxicology Testing Market
4.1 Global In-Vitro Toxicology Testing Market by Region
4.2.1 Market by Product & Service: Consumables, Assays (Bacterial Toxicity Assays, Enzyme Toxicity Assays, Cell-Based Elisa & Western Blots, Receptor-Binding Assays, Tissue Culture Assays, and Other Assays), Equipment, Software, and Services
4.2.2 Market by Method: Cellular Assays, Biochemical Assays, In Silico Models, and Ex Vivo Models
4.2.3 Market by Toxicity Endpoint & Test: ADME, Skin Irritation, Corrosion, & Sensitization, Genotoxicity Testing, Cytotoxicity Testing, Ocular Toxicity, Organ Toxicity, Phototoxicity Testing, Dermal Toxicity, and Other Toxicity Endpoints & Tests
4.2.4 Market by End Use Industry: Pharmaceuticals & Biopharmaceuticals, Cosmetic & Household Products, Food, and Chemicals
4.2.5 Market by Technology: Cell Culture Technologies, High-Throughput Technologies, and Toxicogenomics
4.2.6 The United States In-Vitro Toxicology Testing Market
4.2.7 The Canadian In-Vitro Toxicology Testing Market
4.2.8 The Mexican In-Vitro Toxicology Testing Market
4.3.1 Market by Product & Service: Consumables, Assays (Bacterial Toxicity Assays, Enzyme Toxicity Assays, Cell-Based Elisa & Western Blots, Receptor-Binding Assays, Tissue Culture Assays, and Other Assays), Equipment, Software, and Services
4.3.2 Market by Method: Cellular Assays, Biochemical Assays, In Silico Models, and Ex Vivo Models
4.3.3 Market by Toxicity Endpoint & Test: ADME, Skin Irritation, Corrosion, & Sensitization, Genotoxicity Testing, Cytotoxicity Testing, Ocular Toxicity, Organ Toxicity, Phototoxicity Testing, Dermal Toxicity, and Other Toxicity Endpoints & Tests
4.3.4 Market by End Use Industry: Pharmaceuticals & Biopharmaceuticals, Cosmetic & Household Products, Food, and Chemicals
4.3.5 Market by Technology: Cell Culture Technologies, High-Throughput Technologies, and Toxicogenomics
4.3.6 The United Kingdom In-Vitro Toxicology Testing Market
4.3.7 The Spanish In-Vitro Toxicology Testing Market
4.3.8 The German In-Vitro Toxicology Testing Market
4.3.9 The French In-Vitro Toxicology Testing Market
4.4.1 Market by Product & Service: Consumables, Assays (Bacterial Toxicity Assays, Enzyme Toxicity Assays, Cell-Based Elisa & Western Blots, Receptor-Binding Assays, Tissue Culture Assays, and Other Assays), Equipment, Software, and Services
4.4.2 Market by Method: Cellular Assays, Biochemical Assays, In Silico Models, and Ex Vivo Models
4.4.3 Market by Toxicity Endpoint & Test: ADME, Skin Irritation, Corrosion, & Sensitization, Genotoxicity Testing, Cytotoxicity Testing, Ocular Toxicity, Organ Toxicity, Phototoxicity Testing, Dermal Toxicity, and Other Toxicity Endpoints & Tests
4.4.4 Market by End Use Industry: Pharmaceuticals & Biopharmaceuticals, Cosmetic & Household Products, Food, and Chemicals
4.4.5 Market by Technology: Cell Culture Technologies, High-Throughput Technologies, and Toxicogenomics
4.4.6 The Chinese In-Vitro Toxicology Testing Market
4.4.7 The Indian In-Vitro Toxicology Testing Market
4.4.8 The Japanese In-Vitro Toxicology Testing Market
4.5.1 Market by Product & Service: Consumables, Assays (Bacterial Toxicity Assays, Enzyme Toxicity Assays, Cell-Based Elisa & Western Blots, Receptor-Binding Assays, Tissue Culture Assays, and Other Assays), Equipment, Software, and Services
4.5.2 Market by Method: Cellular Assays, Biochemical Assays, In Silico Models, and Ex Vivo Models
4.5.3 Market by Toxicity Endpoint & Test: ADME, Skin Irritation, Corrosion, & Sensitization, Genotoxicity Testing, Cytotoxicity Testing, Ocular Toxicity, Organ Toxicity, Phototoxicity Testing, Dermal Toxicity, and Other Toxicity Endpoints & Tests
4.5.4 Market by End Use Industry: Pharmaceuticals & Biopharmaceuticals, Cosmetic & Household Products, Food, and Chemicals
4.5.5 Market by Technology: Cell Culture Technologies, High-Throughput Technologies, and Toxicogenomics
4.5.6 Brazilian In-Vitro Toxicology Testing Market
7.1.1 Growth Opportunities for the Global In-Vitro Toxicology Testing Market by Product and Service
7.1.2 Growth Opportunities for the Global In-Vitro Toxicology Testing Market by Methpd
7.1.3 Growth Opportunities for the Global In-Vitro Toxicology Testing Market by Toxicity Endpoint & Test
7.1.4 Growth Opportunities for the Global In-Vitro Toxicology Testing Market by End Use Industry
7.1.5 Growth Opportunities for the Global In-Vitro Toxicology Testing Market by Technology
7.1.6 Growth Opportunities for the Global In-Vitro Toxicology Testing Market by Region
Methodology
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in this market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.
